Allice drugs have four business verticals, which are API, Finished Formulation, Pallets & Contract Research and Manufacturing. Allice drugs is planning to work with global pharmaceutical companies for its fermentation and semi-synthetic complex niche API’s in the area of Immunosuppressant, Oncology, Antibacterial, Cepha section,PPI:s,Neutracetical and Antifungal segments. Quality is prime focus at Allice drugs and we believe in one product-one process for the global markets, with which we shall file our DMF’s globally. Allice drugs shall be known as a trusted & reliable supply partner for the API’s meeting global regulatory compliances. Understanding Client’s need and meeting their requirement within a defined timeline shall be the key to Allice drugs success. Allice drugs shall launch many products over the years to come and has a robust product pipeline. Allice drugs have planned to develop and commercialize portfolio of complex and difficult to make formulations targeting the worldwide markets. Company has planned to commercially selling its products in the USA and other global markets. The products comprise of Oral Solids (tablets & capsules), Oral liquids and Suspensions across therapeutic segments like Immunosuppressant, Nephrology Drugs and Anti-infective for critical care. Leveraging its core competence and expertise in the area of fermentation and semi-synthesis API’s and development of complex formulations, Allice drugs has planned to provide services from conceptualization to commercialization to global companies as part of its Contract Research & Manufacturing business.